The development of this non-promotional presentation has been funded by AstraZeneca UK and was created by Dr Elaine Vickers (Science Communicated Ltd). This presentation is titled ‘Treatments that target B cell receptor signalling and Bcl-2’. This resource covers:
- Treatment classes that target B cell receptor-controlled signalling pathways
- Treatments that block a powerful survival protein called Bcl-2
Only to be shared with relevant UK haematology healthcare professionals.
CPD® Accreditation
To support your continued professional development the resources hosted in the Resources hub have been certified for CPD® accreditation by the CPD® Certification Service.
Please complete the Request CPD® Certificate form to request a CPD® accredited certificate.
